BASAL CELL CARCINOMA

This study tests two immunotherapy drugs, nivolumab and ipilimumab, in adults with over 50 types of rare cancers. The goal is to see if this drug combination can shrink tumors or stop them from growing. The trial is no longer enrolling new participants, but results will help guid…

This study tests whether a special camera (OCT) can help doctors aim a laser more precisely at basal cell skin cancers. About 40 adults with a confirmed BCC will get laser treatment guided by OCT. The goal is to see if the cancer is fully removed without needing standard surgery.

This study tests whether using special cameras (reflectance confocal microscopy and optical coherence tomography) to guide radiation therapy can effectively treat basal cell carcinoma, a common skin cancer. About 38 adults with early-stage tumors will receive this targeted radiat…

This study tests a drug called RP1, which is injected directly into skin cancer tumors. It is for people who have had an organ or stem cell transplant and now have advanced skin cancer. The goal is to see if RP1 can shrink tumors safely without harming the transplanted organ. Abo…

This study tests a new type of radiation called FLASH, which delivers treatment in a fraction of a second, against standard radiotherapy for people with localized skin cancers (basal cell or squamous cell carcinoma). The goal is to see if FLASH can control the tumor just as well …

This study tests an experimental drug called BO-112, injected directly into skin cancer tumors (basal cell carcinoma) before they are surgically removed. The goal is to see if the drug can shrink or eliminate the cancer and to check for side effects. About 60 adults with low- or …

This early-phase study tests whether a mix of drugs and targeted radiation can help the immune system recognize and attack hard-to-treat solid tumors. About 14 adults with advanced melanoma, breast cancer, or other solid cancers that cannot be surgically removed will receive inje…

This study follows 26 adults with small basal cell carcinomas (a common skin cancer) for up to 3 years. Researchers use special cameras and imaging to measure how the tumors grow, without providing any treatment. The goal is to learn more about these cancers and find better ways …